4SC

Welcome to the Brand page for “4SC”, which is offered here for The mark consists of wording 4sc to the left of a stylized design of three interlocked circles with a separate circle above and below the interlocked circles.;pharmaceutical preparations and substances for the treatment or prevention of inflammatory diseases and disorders; pharmaceutical preparations and substances for the treatment or prevention of fibrosis and other diseases and disorders related to aberrant cell proliferation other than cancer,; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations for the treatment of immune system related diseases and disorders;color is not claimed as a feature of the mark.;development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; pharmaceutical research services; biological research, clinical research and medical research in the field of cancer, immune system related diseases and disorders, inflammatory diseases and disorders, and fibrosis and other diseases and disorders related to aberrant cell proliferation other than cancer;.

Its status is currently believed to be active. Its class is unavailable. “4SC” is believed to be currently owned by “4SC AG”.

Owner:
4SC AG
Owner Details
Description:
The mark consists of wording 4SC to the left of a stylized design of three interlocked circles with a separate circle above and below the interlocked circles.;Pharmaceutical preparations and substances for the treatment or prevention of inflammatory diseases and disorders; pharmaceutical preparations and substances for the treatment or prevention of fibrosis and other diseases and disorders related to aberrant cell proliferation other than cancer,; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations for the treatment of immune system related diseases and disorders;Color is not claimed as a feature of the mark.;Development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; pharmaceutical research services; biological research, clinical research and medical research in the field of cancer, immune system related diseases and disorders, inflammatory diseases and disorders, and fibrosis and other diseases and disorders related to aberrant cell proliferation other than cancer;
Categories: